Angela Pierce - Publications

Affiliations: 
1998-2000 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 

7/90 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Dahl NA, Danis E, Balakrishnan I, Wang D, Pierce A, Walker FM, Gilani A, Serkova NJ, Madhavan K, Fosmire S, Green AL, Foreman NK, Venkataraman S, Vibhakar R. Super Elongation Complex as a Targetable Dependency in Diffuse Midline Glioma. Cell Reports. 31: 107485. PMID 32268092 DOI: 10.1016/J.Celrep.2020.03.049  0.358
2020 Moreira DC, Venkataraman S, Subramanian A, Desisto J, Balakrishnan I, Prince E, Pierce A, Griesinger A, Green A, Eberhardt CG, Foreman NK, Vibhakar R. Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine. Journal of Neuro-Oncology. PMID 32180106 DOI: 10.1007/S11060-020-03457-0  0.3
2019 Veo B, Danis E, Pierce A, Sola I, Wang D, Foreman NK, Jin J, Ma A, Serkova N, Venkataraman S, Vibhakar R. Combined functional genomic and chemical screens identify SETD8 as a therapeutic target in MYC-driven medulloblastoma. Jci Insight. 4. PMID 30626740 DOI: 10.1172/Jci.Insight.122933  0.363
2018 Alimova I, Pierce A, Danis E, Donson A, Birks DK, Griesinger A, Foreman NK, Santi M, Soucek L, Venkataraman S, Vibhakar R. Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1 deficient Group 2 Atypical Teratoid Rhabdoid Tumors to suppress tumor growth in vivo. International Journal of Cancer. PMID 30230537 DOI: 10.1002/Ijc.31873  0.344
2018 Morin A, Soane C, Pierce A, Alimova I, Desmarais M, Zahedi S, Vibhakar R, Griesinger A, Green A, Hoffman L, Levy JM. Atrt-18. Validation Of Proteasome Inhibition As A Therapeutic Target In Atypical Teratoid/Rhabdoid Tumors Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.016  0.318
2014 Kavitha CV, Jain AK, Agarwal C, Pierce A, Keating A, Huber KM, Serkova NJ, Wempe MF, Agarwal R, Deep G. Asiatic acid induces endoplasmic reticulum stress and apoptotic death in glioblastoma multiforme cells both in vitro and in vivo. Molecular Carcinogenesis. PMID 25252179 DOI: 10.1002/Mc.22220  0.313
2002 Sclafani RA, Tecklenburg M, Pierce A. The mcm5-bob1 bypass of Cdc7p/Dbf4p in DNA replication depends on both Cdk1-independent and Cdk1-dependent steps in Saccharomyces cerevisiae. Genetics. 161: 47-57. PMID 12019222  0.498
Low-probability matches (unlikely to be authored by this person)
2018 Sola I, Venkataraman S, Pierce A, Balakrishnan I, Birks D, Foreman NK, Vibhakar R. Mbrs-22. Ezh2 Overexpression Increases The Oncogenic Character Of Cerebellar Progenitors And Isografts In Mice Result In Tumors Resembling Group 3 Medulloblastoma Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.467  0.293
2017 Alimova I, Pierce AM, Harris P, Donson A, Birks DK, Prince E, Balakrishnan I, Foreman NK, Kool M, Hoffman L, Venkataraman S, Vibhakar R. Targeting Polo-like kinase 1 in SMARCB1 deleted atypical teratoid rhabdoid tumor. Oncotarget. 8: 97290-97303. PMID 29228610 DOI: 10.18632/oncotarget.21932  0.291
2018 Madhavan K, Balakrishnan I, Pierce A, Venkataraman S, Vibhakar R. Phrm-02. Delivery Of Chemotherapeutics To Pediatric Brain Tumors Using Citrate-Capped Gold Nanoparticles Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.580  0.288
2019 Steiner J, Pierce A, Griesinger A, Veo B, Knox A, Dahl N, Green A, Foreman N, Vibhakar R, Serkova N. TMOD-07. ADVANCED ULTRA-HIGH FIELD MRI ON TUMOR HABITAT IN ORTHOTOPIC MOUSE MODELS FOR PEDIATRIC BRAIN TUMORS Neuro-Oncology. 21: ii122-ii122. DOI: 10.1093/Neuonc/Noz036.245  0.285
2002 Pierce A. Tumors and Cysts of the Jaws. Atlas of Tumor Pathology: Third Series Pathology. 34: 299. DOI: 10.1080/00313020212470  0.279
2014 Salian-Mehta S, Xu M, Pierce A, Bliesner B, Tobet S, Wierman ME. Loss of Growth arrest specific gene 6 (Gas6) results in altered GnRH neuron migration, delayed vaginal opening and sexual maturation in mice Molecular and Cellular Endocrinology. 393: 164-170. PMID 24978606 DOI: 10.1016/J.Mce.2014.06.015  0.278
2012 Wierman ME, Xu M, Pierce A, Bliesner B, Bliss SP, Roberson MS. Extracellular signal-regulated kinase 1 and 2 are not required for GnRH neuron development and normal female reproductive axis function in mice. Neuroendocrinology. 95: 289-96. PMID 22156655 DOI: 10.1159/000331389  0.277
2011 Pierce A, Xu M, Bliesner B, Liu Z, Richards J, Tobet S, Wierman ME. Hypothalamic but not pituitary or ovarian defects underlie the reproductive abnormalities in Axl/Tyro3 null mice. Molecular and Cellular Endocrinology. 339: 151-8. PMID 21539887 DOI: 10.1016/J.Mce.2011.04.007  0.273
2018 Balakrishnan I, Madhavan K, Pierce A, Dahl N, Lemma R, Fosmire S, Wang D, Prince E, Alimova I, Hashizume R, Huellman E, Hawkins C, Carcaboso AM, Gupta N, Monje M, et al. Dipg-55. Targeting Senescent Cells With Abt-263 Enhances Cell Death Induced By Bmi1 Inhibition And Ionizing Radiation In Dipg Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.148  0.267
2022 Alimova I, Wang D, Danis E, Pierce A, Donson A, Serkova N, Madhavan K, Lakshmanachetty S, Balakrishnan I, Foreman NK, Mitra S, Venkataraman S, Vibhakar R. Targeting the TP53/MDM2 axis enhances radiation sensitivity in atypical teratoid rhabdoid tumors. International Journal of Oncology. 60. PMID 35179215 DOI: 10.3892/ijo.2022.5322  0.265
2008 Pierce A, Bliesner B, Xu M, Nielsen-Preiss S, Lemke G, Tobet S, Wierman ME. Axl and Tyro3 modulate female reproduction by influencing gonadotropin-releasing hormone neuron survival and migration. Molecular Endocrinology (Baltimore, Md.). 22: 2481-95. PMID 18787040 DOI: 10.1210/Me.2008-0169  0.265
2019 Sola I, Fosmire S, Venkataraman S, Balakrishnan I, Birks D, Pierce A, Foreman NK, Vibhakar R. Medu-19. Ezh2-Regulated Inhibition Of Hipk2 Suppresses Treatment-Induced Apoptosis In Group 3 Medulloblastoma Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz036.178  0.262
2020 Wang D, Pierce A, Veo B, Fosmire S, Madhavan K, Balakrishnan I, Venkataraman S, Vibhakar R. MBRS-65. FBXW7 ACTS A TUMOR SUPPRESSOR IN MYC-DRIVEN MEDULLOBLASTOMA BY CONTROLLING A FEED-FORWARD REGULATORY LOOP OF PLK1 AND MYC Neuro-Oncology. 22: iii409-iii409. DOI: 10.1093/neuonc/noaa222.569  0.255
2020 Balakrishnan I, Danis E, Pierce A, Madhavan K, Wang D, Dahl N, Bridget S, Birks DK, Davidson N, Metselaar DS, Neel H, Donson A, Griesinger A, Katagi H, Vijmasi T, et al. DIPG-73. SENESCENCE ASSOCIATED SECRETORY PHENOTYPE AS A MECHANISM OF RESISTANCE AND THERAPEUTIC VULNERABILITY IN BMI1 INHIBITOR TREATED DIPG Neuro-Oncology. 22: iii301-iii301. DOI: 10.1093/neuonc/noaa222.115  0.252
2021 Wang D, Pierce A, Veo B, Fosmire S, Danis E, Donson A, Venkataraman S, Vibhakar R. A Regulatory Loop of FBXW7-MYC-PLK1 Controls Tumorigenesis of MYC-Driven Medulloblastoma. Cancers. 13. PMID 33494392 DOI: 10.3390/cancers13030387  0.252
2017 Veo B, Venkataraman S, Pierce A, Foreman N, Vibhakar R. MEDU-35. AN EPIGENOME FOCUSED RNAI SCREEN REVEALS SETD8 AS A KEY REGULATOR OF MYC DRIVEN MEDULLOBLASTOMA Neuro-Oncology. 19: iv45-iv45. DOI: 10.1093/Neuonc/Nox083.185  0.252
2020 Balakrishnan I, Danis E, Pierce A, Madhavan K, Wang D, Dahl N, Sanford B, Birks DK, Davidson N, Metselaar DS, Meel MH, Lemma R, Donson A, Vijmasi T, Katagi H, et al. Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG. Cell Reports. 33: 108286. PMID 33086074 DOI: 10.1016/j.celrep.2020.108286  0.251
2021 Wang D, Veo B, Pierce A, Fosmire S, Madhavan K, Balakrishnan I, Donson A, Alimova I, Sullivan KD, Joshi M, Erlander M, Ridinger M, Foreman NK, Venkataraman S, Vibhakar R. A novel PLK1 inhibitor onvansertib effectively sensitizes MYC-driven medulloblastoma to radiotherapy. Neuro-Oncology. PMID 34477871 DOI: 10.1093/neuonc/noab207  0.247
2020 Abdel-Hafiz A, Madhavan K, Balakrishnan I, Pierce A, Wang D, Danis E, Serkova N, Venkataraman S, Vibhakar R. MBRS-71. ATAXIA TELANGIECTASIA AND RAD3-RELATED PROTEIN ATTENUATES DNA DAMAGE AND IS A THERAPEUTIC TARGET IN Myc-DRIVEN MEDULLOBLASTOMA Neuro-Oncology. 22: iii411-iii411. DOI: 10.1093/neuonc/noaa222.575  0.243
2014 Knubel KH, Pernu BM, Sufit A, Nelson S, Pierce AM, Keating AK. MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme Oncotarget. 5: 1338-1351. PMID 24658326  0.243
2023 Alimova I, Murdock G, Pierce A, Wang D, Madhavan K, Brunt B, Venkataraman S, Vibhakar R. The PARP inhibitor Rucaparib synergizes with radiation to attenuate atypical teratoid rhabdoid tumor growth. Neuro-Oncology Advances. 5: vdad010. PMID 36915612 DOI: 10.1093/noajnl/vdad010  0.239
2018 Danis E, Pierce A, Balakrishan I, Wang D, Venkataraman S, Vibhakar R. Mbrs-48. Deciphering And Targeting Ezh2 Overexpression In Medulloblastoma Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.493  0.239
1988 Pierce A, Berg J, Lindskog S. Calcitonin as an alternative therapy in the treatment of root resorption. Journal of Endodontics. 14: 459-464. PMID 3273316 DOI: 10.1016/S0099-2399(88)80136-5  0.237
2020 Dahl N, Danis E, Balakrishnan I, Wang D, Pierce A, Walker F, Gilani A, Serkova N, Madhaven K, Fosmire S, Green A, Foreman N, Venkataraman S, Vibhakar R. DIPG-34. SUPER ELONGATION COMPLEX AS A TARGETABLE DEPENDENCY IN H3K27M+ DIFFUSE MIDLINE GLIOMA Neuro-Oncology. 22: iii293-iii293. DOI: 10.1093/neuonc/noaa222.082  0.237
2019 Veo B, Fosmire S, Wang D, Madhavan K, Pierce A, Venkataraman S, Vibhakar R. MEDU-13. FUNCTIONAL CRISPR-CAS9 SCREEN IDENTIFIES DRUGGABLE DEPENDENCIES IN MYC-DRIVEN MEDULLOBLASTOMA Neuro-Oncology. 21: ii105-ii106. DOI: 10.1093/Neuonc/Noz036.172  0.236
2021 Veo B, Danis E, Pierce A, Wang D, Fosmire S, Sullivan KD, Joshi M, Khanal S, Dahl N, Karam S, Serkova N, Venkataraman S, Vibhakar R. Transcriptional control of DNA repair networks by CDK7 regulates sensitivity to radiation in MYC-driven medulloblastoma. Cell Reports. 35: 109013. PMID 33910002 DOI: 10.1016/j.celrep.2021.109013  0.234
2018 Witt D, Griesinger A, Hansen J, Venkataraman S, Balakrishnan I, Pierce A, Alimova I, Donson A, Amani V, Vibhakar R, Foreman N. Epen-20. Identification And Investigation Of A Novel Epigenetic Modulator In Posterior Fossa Ependymoma, Sirt2 Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.221  0.233
2016 Sufit A, Lee-Sherick AB, DeRyckere D, Rupji M, Dwivedi B, Varella-Garcia M, Pierce AM, Kowalski J, Wang X, Frye SV, Earp HS, Keating AK, Graham DK. MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme. Plos One. 11: e0165107. PMID 27783662 DOI: 10.1371/Journal.Pone.0165107  0.23
1988 Lindskog S, Pierce A. Spreading of dentinoclasts on various substrata in vitro European Journal of Oral Sciences. 96: 310-316. PMID 3166195 DOI: 10.1111/J.1600-0722.1988.Tb01561.X  0.229
2020 Alimova I, Danis E, Weetall M, Pierce AM, Wang D, Serkova N, Balakrishnan I, Madhavan K, Sanford B, Michel C, Foreman NK, Baird J, Venkataraman S, Vibhakar R. ATRT-06. SMARCB1 LOSS DRIVEN NON-CANONICAL PRC1 ACTIVITY REGULATES DIFFERENTIATION IN ATYPICAL TERATOID RHABDOID TUMORS (ATRT) Neuro-Oncology. 22: iii276-iii277. DOI: 10.1093/neuonc/noaa222.006  0.228
2018 Veo B, Venkataraman S, Pierce A, Sola I, Foreman N, Vibhakar R. MBRS-11. THE EPIGENETIC REGULATOR, SETD8, FACILITATES SELF-RENEWAL AND INVASION IN MYC-DRIVEN MEDULLOBLASTOMA Neuro-Oncology. 20: i130-i130. DOI: 10.1093/Neuonc/Noy059.456  0.228
2008 Moore S, Johnson N, Pierce A, Wilson D. The epidemiology of lip cancer: a review of global incidence and aetiology. Oral Diseases. 5: 185-195. PMID 10483063 DOI: 10.1111/J.1601-0825.1999.Tb00300.X  0.226
2012 Rogers AE, Le JP, Sather S, Pernu BM, Graham DK, Pierce AM, Keating AK. Mer receptor tyrosine kinase inhibition impedes glioblastoma multiforme migration and alters cellular morphology. Oncogene. 31: 4171-81. PMID 22179835 DOI: 10.1038/Onc.2011.588  0.222
2024 Wang D, Ritz C, Pierce A, Brunt B, Luo Y, Dahl N, Venkataraman S, Danis E, Kuś K, Mazan M, Rzymski T, Veo B, Vibhakar R. Transcriptional Regulation of Protein Synthesis by Mediator Kinase in MYC-driven Medulloblastoma. Biorxiv : the Preprint Server For Biology. PMID 38559100 DOI: 10.1101/2024.03.08.584103  0.221
2020 Veo B, Danis E, Fosmire S, Wang D, Pierce A, Dahl N, Karam S, Serkova N, Venkataraman S, Vibhakar R. MBRS-26. CDK7 MEDIATED TRANSCRIPTIONAL PROCESSIVITY OF DNA REPAIR NETWORKS REGULATES SENSITIVITY TO RADIATION IN MYC DRIVEN MEDULLOBLASTOMA Neuro-Oncology. 22: iii403-iii403. DOI: 10.1093/neuonc/noaa222.541  0.22
2020 Morin A, Soane C, Pierce A, Sanford B, Jones KL, Crespo M, Zahedi S, Vibhakar R, Mulcahy Levy JM. Proteasome inhibition as a therapeutic approach in atypical teratoid/rhabdoid tumors. Neuro-Oncology Advances. 2: vdaa051. PMID 32642704 DOI: 10.1093/noajnl/vdaa051  0.219
2019 Griesinger A, Donson A, Amani V, Domman A, Pierce A, Court BV, Karam S, Steiner J, Serkova N, Dorris K, Foreman N. EPEN-10. 5-FU ENHANCES RADIATION THERAPY IN IN VITRO AND IN VIVO TREATMENT OF 1q+ PFA EPENDYMOMA Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz036.067  0.218
1987 Wedenberg C, Pierce A, Lindskog S. Resorbing potential of different connective tissue types. European Journal of Oral Sciences. 95: 270-271. PMID 3474769 DOI: 10.1111/J.1600-0722.1987.Tb01841.X  0.217
2008 Moore S, Johnson N, Pierce A, Wilson D. The epidemiology of mouth cancer: a review of global incidence. Oral Diseases. 6: 65-74. PMID 10702782 DOI: 10.1111/J.1601-0825.2000.Tb00104.X  0.216
2004 Lawler B, Pierce A, Sambrook PJ, Jones RHB, Goss AN. The diagnosis and surgical management of major salivary gland pathology. Australian Dental Journal. 49: 9-15. PMID 15104128 DOI: 10.1111/J.1834-7819.2004.Tb00043.X  0.216
2008 Ortiz G, Pierce A, Wilson D. Palatal changes associated with reverse smoking in Filipino women Oral Diseases. 2: 232-237. PMID 9081765 DOI: 10.1111/J.1601-0825.1996.Tb00230.X  0.215
1989 Pierce A. Pathophysiological and therapeutic aspects of dentoalveolar resorption Australian Dental Journal. 34: 437-448. PMID 2510708 DOI: 10.1111/J.1834-7819.1989.Tb00702.X  0.21
1998 Pierce A. Pulpal injury: Pathology, diagnosis and periodontal reactions Australian Endodontic Journal. 24: 60-65. PMID 11431815 DOI: 10.1111/J.1747-4477.1998.Tb00009.X  0.209
2008 Moore S, Pierce A, Wilson D. 'Oral cancer'--the terminology dilemma. Oral Diseases. 6: 191-193. DOI: 10.1111/J.1601-0825.2000.Tb00332.X  0.208
2023 Martinez P, Nault G, Steiner J, Wempe MF, Pierce A, Brunt B, Slade M, Mongin A, Song J, Song KH, Ellens N, Serkova N, Green A, Borden M. MRI-Guided Focused Ultrasound Blood-Brain Barrier Opening Increases Drug Delivery and Efficacy in a Diffuse Midline Glioma Mouse Model. Biorxiv : the Preprint Server For Biology. PMID 37066205 DOI: 10.1101/2023.04.05.534448  0.201
2018 Griesinger A, Pierce A, Witt D, Flannery P, Donson A, Gowan K, Hankinson T, Handler M, Jones K, Green A, Vibhakar R, Foreman N. Epen-16. Patient-Derived Pfa Ependymoma Xenograft Model Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.217  0.2
2023 Walker FM, Sobral LM, Danis E, Sanford B, Balakrishnan I, Wang D, Pierce A, Karam SD, Serkova NJ, Foreman NK, Venkataraman S, Dowell R, Vibhakar R, Dahl NA. Rapid PTEFb-dependent transcriptional reorganization underpins the glioma adaptive response to radiotherapy. Biorxiv : the Preprint Server For Biology. PMID 36747867 DOI: 10.1101/2023.01.24.525424  0.2
2023 Wolin AR, Vincent MY, Hotz T, Purdy SC, Rosenbaum SR, Hughes CJ, Hsu JY, Oliphant MUJ, Armstrong B, Wessells V, Varella-Garcia M, Galbraith MD, Pierce A, Wang D, Venkataraman S, et al. EYA2 Tyrosine Phosphatase Inhibition Reduces MYC and Prevents Medulloblastoma Progression. Neuro-Oncology. PMID 37486991 DOI: 10.1093/neuonc/noad128  0.197
1998 Pierce AM, Gimenez-Conti IB, Schneider-Broussard R, Martinez LA, Conti CJ, Johnson DG. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proceedings of the National Academy of Sciences of the United States of America. 95: 8858-63. PMID 9671769 DOI: 10.1073/PNAS.95.15.8858  0.188
2020 Madhavan K, Veo B, Danis E, Balakrishnan I, Pierce A, Wang D, Abdel-Hafiz A, Serkova N, Dahl N, Venkataraman S, Vibhakar R. MBRS-67. ROLE OF CYCLIN DEPENDENT KINASE-9 IN Myc-ENHANCED MEDULLOBLASTOMA Neuro-Oncology. 22: iii410-iii410. DOI: 10.1093/neuonc/noaa222.571  0.186
1998 Pierce AM, Fisher SM, Conti CJ, Johnson DG. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development. Oncogene. 16: 1267-76. PMID 9546428 DOI: 10.1038/sj.onc.1201666  0.182
2015 Alimova I, Venkataraman S, Pierce A, Greisinger A, Birks D, Balakrishnan I, Foreman N, Vibhakar R. AT-04 * TARGETING Myc DRIVEN TRANSCRIPTIONAL OUTPUT IN ATYPICAL TERATOID RHABDOID TUMOR Neuro-Oncology. 17: iii1-iii2. DOI: 10.1093/NEUONC/NOV061.4  0.177
2022 Madhavan K, Balakrishnan I, Lakshmanachetty S, Pierce A, Sanford B, Fosmire S, Elajaili HB, Walker F, Wang D, Nozik ES, Mitra SS, Dahl NA, Vibhakar R, Venkataraman S. Venetoclax cooperates with ionizing radiation to attenuate Diffuse Midline Glioma tumor growth. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 35344040 DOI: 10.1158/1078-0432.CCR-21-4002  0.176
2020 Serkova N, Stukova M, Henehan S, Steiner J, Pierce A, Griesinger A, Veo B, Alimova I, Venkataraman S, Green A, Dahl N, Foreman N, Vibhakar R. IMG-17. RADIOMICS CHARACTERIZATION OF FOUR PEDIATRIC BRAIN TUMOR SUBTYPES IN PDX MOUSE MODELS Neuro-Oncology. 22: iii358-iii358. DOI: 10.1093/neuonc/noaa222.352  0.175
2014 Pierce AM, Keating AK. Creating anatomically accurate and reproducible intracranial xenografts of human brain tumors Journal of Visualized Experiments. PMID 25285381 DOI: 10.3791/52017  0.17
1999 Pierce AM, Schneider-Broussard R, Gimenez-Conti IB, Russell JL, Conti CJ, Johnson DG. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Molecular and Cellular Biology. 19: 6408-14. PMID 10454586 DOI: 10.1128/MCB.19.9.6408  0.168
2023 Martinez P, Nault G, Steiner J, Wempe MF, Pierce A, Brunt B, Slade M, Song JJ, Mongin A, Song KH, Ellens N, Serkova N, Green AL, Borden M. MRI-guided focused ultrasound blood-brain barrier opening increases drug delivery and efficacy in a diffuse midline glioma mouse model. Neuro-Oncology Advances. 5: vdad111. PMID 37795179 DOI: 10.1093/noajnl/vdad111  0.157
1998 Pierce AM, Schneider-Broussard R, Philhower JL, Johnson DG. Differential activities of E2F family members: unique functions in regulating transcription. Molecular Carcinogenesis. 22: 190-8. PMID 9688145 DOI: 10.1002/(SICI)1098-2744(199807)22:3<190::AID-MC7>3.0.CO;2-P  0.153
2014 Pierce AM, Keating AK. TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system Brain Research. 1542: 206-220. PMID 24184575 DOI: 10.1016/j.brainres.2013.10.049  0.149
2019 Pierce AM, Witt DA, Donson AM, Gilani A, Sanford B, Sill M, Van Court B, Oweida A, Prince EW, Steiner J, Danis E, Dorris K, Hankinson T, Handler MH, Jones KL, et al. Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymoma. Neuro-Oncology. PMID 31276586 DOI: 10.1093/Neuonc/Noz116  0.148
2004 Frazer-Abel AA, Baksh S, Fosmire SP, Willis D, Pierce AM, Meylemans H, Linthicum DS, Burakoff SJ, Coons T, Bellgrau D, Modiano JF. Nicotine activates nuclear factor of activated T cells c2 (NFATc2) and prevents cell cycle entry in T cells. The Journal of Pharmacology and Experimental Therapeutics. 311: 758-69. PMID 15231866 DOI: 10.1124/Jpet.104.070060  0.124
2015 Pierce AN, Zhang Z, Fuentes IM, Wang R, Ryals JM, Christianson JA. Neonatal vaginal irritation results in long-term visceral and somatic hypersensitivity and increased hypothalamic-pituitary-adrenal axis output in female mice. Pain. PMID 26098441 DOI: 10.1097/J.Pain.0000000000000264  0.122
2016 Alimova I, Pierce AM, Venkataraman S, Harris P, Birks DK, Amani VM, Prince E, Balakrishnan I, Foreman NK, Vibhakar R. AT-07PLK1 AS A THERAPEUTIC TARGET IN ATRT Neuro-Oncology. 18: iii2.2-iii2. DOI: 10.1093/NEUONC/NOW065.06  0.12
2017 Alimova I, Venkataraman S, Balakrishnan I, Pierce AM, Mulcahy-Levy J, Foreman NK, Vibhakar R. ATRT-07. AN EPIGENOME DIRECTED FUNCTIONAL GENOMIC SCREEN IDENTIFIES SIRT2 AS A SYNTHETIC LETHAL TARGET IN SMARCB1 DEFICIENT ATRT Neuro-Oncology. 19: iv2-iv2. DOI: 10.1093/NEUONC/NOX083.006  0.118
2015 Fuentes IM, Pierce AN, O'Neil PT, Christianson JA. Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation. Journal of Visualized Experiments : Jove. PMID 26327525 DOI: 10.3791/53181  0.114
2018 Alimova I, Venkataraman S, Pierce AM, Birks D, Vibhakar R, Foreman NK, Yang M, Ling H. ATRT-12. TARGETING SIRT2 IN SMARCB1 DEFICIENT ATRT Neuro-Oncology. 20: i29-i30. DOI: 10.1093/NEUONC/NOY059.011  0.105
2017 Fuentes IM, Pierce AN, Di Silvestro ER, Maloney MO, Christianson JA. Differential Influence of Early Life and Adult Stress on Urogenital Sensitivity and Function in Male Mice. Frontiers in Systems Neuroscience. 11: 97. PMID 29379420 DOI: 10.3389/Fnsys.2017.00097  0.101
2016 Pierce AN, Di Silvestro ER, Eller OC, Wang R, Ryals JM, Christianson JA. Urinary bladder hypersensitivity and dysfunction in female mice following early life and adult stress. Brain Research. 1639: 58-73. PMID 26940840 DOI: 10.1016/j.brainres.2016.02.039  0.101
2024 Griesinger AM, Calzadilla AJ, Grimaldo E, Donson AM, Amani V, Pierce AM, Steiner J, Kargar S, Serkova NJ, Bertrand KC, Wright KD, Vibhakar R, Hankinson T, Handler M, Lindsay HB, et al. Development of chromosome 1q+ specific treatment for highest risk pediatric posterior fossa ependymoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 38334950 DOI: 10.1158/1078-0432.CCR-23-3156  0.1
2017 Balakrishnan I, Venkataraman S, Pierce AM, Alimova I, Prince E, Moreira DC, Fosmire S, Madhavan K, Foreman N, Vibhakar R. MEDU-33. PLK1 INHIBITION IN COMBINATION WITH STANDARD THERAPIES FOR MYC-DRIVEN MEDULLOBLASTOMA Neuro-Oncology. 19: iv44-iv44. DOI: 10.1093/NEUONC/NOX083.183  0.099
2016 Fuentes IM, Walker NK, Pierce AN, Holt BR, Di Silvestro ER, Christianson JA. Neonatal maternal separation increases susceptibility to experimental colitis and acute stress exposure in male mice. Ibro Reports. 1: 10-18. PMID 28164167 DOI: 10.1016/J.Ibror.2016.07.001  0.096
2013 Aaberg-Jessen C, Fogh L, Halle B, Jensen V, Brunner N, Kristensen BW, Abe T, Momii Y, Watanabe J, Morisaki I, Natsume A, Wakabayashi T, Fujiki M, Aldaz B, Fabius AWM, ... ... Pierce AM, ... ... Pierce AM, et al. EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 15: iii37-iii61. DOI: 10.1093/Neuonc/Not176  0.083
2000 Xie W, Barwick JL, Simon CM, Pierce AM, Safe S, Blumberg B, Guzelian PS, Evans RM. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes & Development. 14: 3014-23. PMID 11114890 DOI: 10.1101/Gad.846800  0.082
2021 Eller OC, Yang X, Fuentes IM, Pierce AN, Jones BM, Brake AD, Wang R, Dussor G, Christianson JA. Voluntary Wheel Running Partially Attenuates Early Life Stress-Induced Neuroimmune Measures in the Dura and Evoked Migraine-Like Behaviors in Female Mice. Frontiers in Physiology. 12: 665732. PMID 34122137 DOI: 10.3389/fphys.2021.665732  0.08
2020 Fuentes IM, Jones BM, Brake AD, Pierce AN, Eller OC, Supple RM, Wright DE, Christianson JA. Voluntary wheel running improves outcomes in an early life stress-induced model of urologic chronic pelvic pain syndrome in male mice. Pain. PMID 33399417 DOI: 10.1097/j.pain.0000000000002178  0.075
2022 Marks SK, Rodriguez NA, Shah A, Garcia AN, Ritter L, Pierce AN. Clinical Review of Neuromusculoskeletal Complementary and Alternative Approaches for the Treatment of Chronic Pelvic Pain Syndrome. Cureus. 14: e27077. PMID 35989846 DOI: 10.7759/cureus.27077  0.068
2018 Pierce AN, Eller-Smith OC, Christianson JA. Voluntary wheel running attenuates urinary bladder hypersensitivity and dysfunction following neonatal maternal separation in female mice. Neurourology and Urodynamics. 37: 1623-1632. PMID 29464752 DOI: 10.1002/Nau.23530  0.066
2020 Green AL, Flannery P, Hankinson TC, O'Neill B, Amani V, DeSisto J, Knox A, Chatwin H, Lemma R, Hoffman LM, Mulcahy Levy J, Raybin J, Hemenway M, Gilani A, Koschmann C, ... ... Pierce A, et al. Preclinical and clinical investigation of intratumoral chemotherapy pharmacokinetics in DIPG using gemcitabine. Neuro-Oncology Advances. 2: vdaa021. PMID 32642682 DOI: 10.1093/noajnl/vdaa021  0.061
2011 Crisp CA, Pierce AN. Back pain and leg complaints that revealed non-small cell carcinoma: a case study. Journal of Chiropractic Medicine. 10: 185-8. PMID 22014908 DOI: 10.1016/j.jcm.2010.10.006  0.059
2021 Tyler R, Danilova G, Kruse S, Pierce A. Innovations Through Virtual Reality Simulation. Missouri Medicine. 118: 422-425. PMID 34658433  0.055
2015 Pierce AN, Christianson JA. Stress and chronic pelvic pain. Progress in Molecular Biology and Translational Science. 131: 509-35. PMID 25744684 DOI: 10.1016/bs.pmbts.2014.11.009  0.05
2009 O'Hara AH, Sampson WJ, Dreyer CW, Pierce AM, Ferguson IA. Immunohistochemical detection of nerve growth factor and its receptors in the rat periodontal ligament during tooth movement. Archives of Oral Biology. 54: 871-8. PMID 19570523 DOI: 10.1016/j.archoralbio.2009.06.003  0.048
2010 Tomlinson MJ, Pooley K, Pierce A, Hopkisson JF. Sperm donor recruitment within an NHS fertility service since the removal of anonymity. Human Fertility (Cambridge, England). 13: 159-67. PMID 20849201 DOI: 10.3109/14647273.2010.512654  0.038
Hide low-probability matches.